Explorer les evidences

Palier Gold : evidences validées mécaniquement, avec leur source primaire.

381 evidences · page 15 / 16

13 cancersOf 15 biopsy-confirmed cancers, the iBreastExam detected an ipsilateral breast abnormality in 13 (87%) women.

Nigeriacancer du seinpublié 2022The Lancet. Global healthPubMeddocument de 19 observations

419 casesThe study included 419 histologically confirmed cases of breast cancer and 286 healthy controls from the MEND case-control study.

Nigeriacancer du seinpublié 2021BMC cancerPubMeddocument de 5 observations

4,1 %Among all cases, 4.1% carried a loss-of-function mutation in BRCA2.

Nigeriacancer du seinpublié 2018Journal of clinical oncology : official journal of the American Society of Clinical Oncoloeurope_pmcdocument de 14 observations

Breast cancer is the most common cancer and has the highest mortality in Nigeria.

Nigeriacancer du seinpublié 2025American journal of surgeryPubMeddocument de 13 observations

22,7 %In Nigeria, breast cancer accounts for 22.7% of all new cancer cases among women.

Nigeriacancer du seinpublié 2021JCO global oncologyPubMed

53,3 %Malignancy incidence increased with age and peaked in middle-aged women (40–59 years) at 53.30% among the 3,263 breast histopathology records.

Nigeriacancer du seinobservé 2015 to 2023publié 2025Scientific reportsPubMeddocument de 12 observations

64 %64% of respondents had an average income of more than 18,000 naira in a study of breast cancer patients at University College Hospital, Ibadan, Nigeria.

Nigeriacancer du seinobservé 2018publié 2019Journal of global oncologyPubMeddocument de 9 observations

2,8 fold_increasePatients in the highest travel-time quintile had a 2.8-fold increase in the odds of presenting with stage III or IV breast cancer relative to patients in the lowest travel-time quintile.

Nigeriacancer du seinobservé May 2009–January 2019publié 2021CancerPubMeddocument de 7 observations

4,92 mmol/lPost-menopausal women with breast cancer had significantly higher total plasma peroxides (4.92 ± 3.59 mmol/l) compared to controls (2.98 ± 2.82 mmol/l), with P = 0.003.

Nigeriacancer du seinpublié 2021Nigerian journal of clinical practicePubMeddocument de 6 observations

10 %One-tenth of female artisans in Ibadan, Nigeria had ever been screened for breast cancer using clinical breast examination.

Nigeriacancer du seinpublié 2025Women's health (London, England)PubMeddocument de 7 observations

30 %Only 30% of breast cancer patients completed treatment.

Nigeriacancer du seinpublié 2025American journal of surgeryPubMeddocument de 13 observations

10 %Approximately 10% of the 725 health care providers surveyed believed that breast cancer is caused by a spiritual attack.

Nigeriacancer du seinpublié 2020JCO global oncologyPubMeddocument de 7 observations

1,5 risk_ratioVisiting alternative care was associated with a risk ratio of 1.5 for advanced-stage diagnosis after early breast cancer detection.

Nigeriacancer du seinpublié 2021PloS onePubMeddocument de 6 observations

56 %56% of respondents were Yoruba in a study of breast cancer patients at University College Hospital, Ibadan, Nigeria.

Nigeriacancer du seinobservé 2018publié 2019Journal of global oncologyPubMeddocument de 9 observations

34,2 %Luminal A subtype was found in 34.2% of cases.

Nigeriacancer du seinpublié 2024West African journal of medicinePubMeddocument de 13 observations

16,92 scorePost-intervention mean BSE knowledge scores in the modern method group increased to 16.92 ± 2.91.

Nigeriacancer du seinpublié 2024BMC cancerPubMeddocument de 11 observations

78,89 pg/mlPost-menopausal women with breast cancer had significantly higher estradiol (78.89 ± 54.54 pg/ml) compared to controls (11.08 ± 14.80 pg/ml), with P = 0.003.

Nigeriacancer du seinpublié 2021Nigerian journal of clinical practicePubMeddocument de 6 observations

41 %Breast cancer accounted for 41% of 2,420 cancers screened in Lagos State, Nigeria from 2011 to 2020.

Nigeriacancer du seinobservé 2011 to 2020publié 2022JCO global oncologyPubMeddocument de 12 observations

910 patientsThere were 910 breast cancer patients in the institutional database over the decade-long review period.

Nigeriacancer du seinpublié 2023West African journal of medicinePubMeddocument de 8 observations

1,4 odds_ratioA novel breast cancer risk variant in region 5p12 has an odds ratio of 1.40 with a 95% confidence interval of 1.11–1.76 and a p-value of 0.004 in women of African ancestry.

Nigeriacancer du seinpublié 2013Carcinogenesiseurope_pmcdocument de 4 observations

10 %Median tumor-infiltrating lymphocyte (TIL) percentage was 10.0% among 436 treatment-naïve Nigerian breast cancer patients.

Nigeriacancer du seinpublié 2026Breast cancer research and treatmentPubMeddocument de 14 observations

97,1 %340 (97.1%) of the 350 female undergraduates had a positive attitude towards breast cancer screening.

Nigeriacancer du seinpublié 2022African health sciencesPubMeddocument de 5 observations

31,96 μmol/lPost-menopausal women with breast cancer had significantly higher nitric oxide (31.96 ± 10.73 μmol/l) compared to controls (23.92 ± 6.37 μmol/l), with P < 0.001.

Nigeriacancer du seinpublié 2021Nigerian journal of clinical practicePubMeddocument de 6 observations

45,07 %45.07% of the respondents had poor knowledge of breast self-examination.

Nigeriacancer du seinpublié 2023BMC women's healthPubMeddocument de 12 observations

27 %27% of the tumors were luminal A.

Nigeriacancer du seinpublié 2009Journal of clinical oncology : official journal of the American Society of Clinical Oncoloeurope_pmcdocument de 12 observationsDOI 10.1200/jco.2008.19.6873

Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.